Research 
Poster Presentations
updated 14.10.2019
| 61. | Gil-Gómez A, Ampuero J, Gallego-Durán R, Fassina G, Ferrer MT, Liu C, Pontisso P, Romero-Gómez M. Utility of SCCA-IgM levels in the prediction of hepatocellular carcinoma in cirrhotic patients. EASL HCC Summit. Geneva, Switzerland. 2017. |
| 60. | Ricco G, Cavallone D, Pontisso P, Fassina G, Gallotta A, Colombatto P, Oliveri F, Romagnoli V, Coco B, Salvati A, Bonino F, Brunetto MR. In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapy. EASL International Liver Congress (ILC). Amsterdam, Holland. 2017. |
| 59. | Ricco G, Cavallone D, Pontisso P, Fassina G, Gallotta A, Colombatto P, Oliveri F, Romagnoli V, Coco B, Salvati A, Bonino F, Brunetto MR. Squamous Cell Carcinoma Antigen (SCCA)-IgM levels kinetics during direct-acting antivirals (DAAs) in HCV infected patients with cirrhosis: a possible role to identify the individual risk of HCC development. Liver Gymnasium 4. Padova, Italy. 2017. |
| 58. | Francavilla S, Ferretti S, Gnocchi C, Dipalo M, Aloe R, Gallotta A, Fassina G, Ziglioli C, Simeone U, Maestroni U. Clinical evaluation of immune complex predictive index (iXip) to avoid unnecessary negative biopsies for prostate cancer. 89° Congresso SIU. Venice, Italy. 2016. |
| 57. | Paneghetti L, Pontisso P, Gion M, Fassina G. Valutazione economica di un sistema di monitoraggio mediante ecografia epatica implementato con un nuovo biomarcatore per i pazienti con cirrosi a rischio di tumore epatico. Congresso Nazionale della Società Italiana di Health Technology Assessment (siHTA). Riva del Garda (TN), Italy. 2016. |
| 56. | Pontisso P, Paneghetti L, Fassina G. An Updated Systematic Review and Meta-Analysis of SCCA-IgM biomarker (Hepa-IC) for the clinical management of HCV-positive patients.. 16th Iranian Int. Congress Gastroenterol. Hepatol.. Tehran, Iran. 2016. |
| 55. | Gallotta A, Mràzovà V, Bednàrovà A, Kruzlicovà D, Frecer V, Miertus S, Fattovich G, Biasiolo A, Martini A, Ieluzzi D, Guido M, Pontisso P, Fassina G. A novel algorithm based on serum SCCA-IgM determination combined with common clinical data improves prediction of histological NASH. Monothematic Conference of the Italian Association of the Study of the Liver (AISF). Modena, Italy. 2015. |
| 54. | Morisco F, Guarino M, Di Costanzo GG, Gallotta A, Fassina G, Tortora R, Tuccillo C, Granata R, Loperto I, Auriemma F, Caporaso N. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients. Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria. 2015. |
| 53. | Biasiolo A, Trotta E, Fasolato S, Tono N, Ruvoletto M, Martini A, Terrin L, Fassina G, Angeli P, Gatta A, Pontisso P. SCCA-IgM is predictive of hepatocellular carcinoma development in patients with HCV cirrhosis. A prospective study. Annual Meeting of the European Association for the Study of the Liver (EASL). London, UK. 2014. |
| 52. | Guarino M, Di Costanzo G G, Gallotta A, Fassina G, Tortora R, Tuccillo C, Auriemma F, Caporaso N, Morisco F. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients. Monothematic Conference of the Italian Association of the Study of the Liver (AISF). Naples, Italy. 2014. |
| 51. | Martini A, Fattovich G, Guido M, Bugianesi E, Biasiolo A, Ieluzzi D, Gallotta A, Fassina G, Merkel C, Gatta A, Negro F, Pontisso P. Genotype 3 and circulating SCCA-IgM are independently associated with histological features of NASH in HCV infected patients. Monothematic Conference of the Italian Association of the Study of the Liver (AISF). Naples, Italy. 2014. |
| 50. | Morisco F, Di Costanzo GG, Guarino M, Tortora R, Loperto I, Auriemma F, Ferraiuoli C, Tuccillo C, Beneduce L, Caporaso N. SCCA-IgM: a biomarker to monitor the outcome of therapy with sorafenib in advanced HCC. National Congress of Digestive Liver Diseases (FISMAD). Bologna, Italy. 2013. |
| 49. | Morisco F, Di Costanzo GG, Guarino M, Tortora R, Loperto I, Clery E, Auriemma F, Tuccillo C, Beneduce L, Caporaso N. Circulating SCCA-IgM complex is able to monitor the success of loco-regional therapy in HCC patients. National Congress of Digestive Liver Diseases (FISMAD). Bologna, Italy. 2013. |
| 48. | Morisco F, Di Costanzo GG, Guarino M, Tortora R, Loperto I, Tuccillo C, Ferraiuoli C, Beneduce L, Auriemma F, Caporaso N. Circulating Scca-IgM Complex Is an Useful Biomarker to Monitor HCC Therapy. The Liver Meeting-American Association for the Study of Liver Diseases (AASLD). Washington DC, USA. 2013. |
| 47. | Biasiolo A, Tono N, Briarava M, Beneduce L, Fassina G, Farinati F, Giacomin A, Matteucci C, Sorrentino R, Nitti D, Gatta A, Pontisso P. Improved diagnostic accuracy for HCC using a combination of IgM-linked biomarkers. Annual Meeting Italian Association for the Study of the Liver (AISF). Rome, Italy. 2011. |
| 46. | Buccione D, Fatti G, Gallotta A, Loggi E, Di Donato R, Testa L, Saitta C, Santi V, Di Micoli A, Fazio V, Picciotto A, Biasiolo A, Pontisso P, Raimondo G, Trevisani F. Serum SCCA-IgM as a predictor of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. Annual Meeting Italian Association for the Study of the Liver (AISF). Rome, Italy. 2011. |
| 45. | Gomiero C, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Matteucci C, Fassina G, Beneduce L. Improved detection of HCC by co-determination of IgM anti-AFP antibodies and AFP-IgM immune complexes. Annual Meeting of the European Association for the Study of the Liver (EASL). Berlin, Germany. 2011. |
| 44. | Yu Y, Fan R, Zhang Y, Yue Y, A Gould K, Thiele G, Klassen LW, Fassina G, Zhang Z, Su K. Anti-neutrophil autoantibodies in tissue damage in systemic lupus erythematosus. Annual Meeting Immunology. Baltimore, USA. 2010. |
| 43. | Biasiolo A, Tono N, Beneduce L, Zuin J, Fassina G, Meo S, Paccagnella L, Mazzucco M, Farinati F, Giacomin A, Vanin V, Aldino M, Miola E, Donà S, Matteucci C, Sorrentino R, Rasi G, Gatta A, Pontisso P. Osteopontin-IgM as a marker for the diagnosis of hepatocellular carcinoma. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 42. | Biasiolo A, Tono N, Quarta S, Beneduce L. SCCA1-IgM and SCCA2-IgM compared with total SCCA-IgM for diagnosis of hepatocellular carcinoma. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 41. | Bucca E, Beneduce L, Leon A, Fabricio A, Michilin S, Meo S, Vitale M, Steffan A, Durante C, Bellucco C, Rizzo A, Berlanda G, Perasole A, Zampieri F, Zuin J, Veggiani G, Fassina G, Gion M. The usefulness of the combination of free CA 15.3 and CA 15.3-IgM complexes for breast cancer diagnosis. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 40. | Gallotta A, Zuin J, Veggiani G, Pengo P, Biasiolo A, Tono N, Gatta A, Pontisso P, Fassina G, Beneduce L. Combining SCCA-IgM and AFP-IgM levels increases accuracy of hepatocellular carcinoma detection. Annual Meeting Italian Association for the Study of the Liver (AISF). Messina, Italy. 2009. |
| 39. | Gallotta A, Zuin J, Veggiani G, Pengo P, Leon A, Gion M, Biasiolo A, Tono N, Gatta A, Pontisso P, Fassina G, Beneduce L. Combination of biomarkers-IgM by logistic regression improves diagnostic accuracy in hepatocellular carcinoma. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 38. | Matteucci C, Sorrentino R, Ettorre G, Bellis L, Antenucci A, Beneduce L, Santoro R, Vennarecci G, Zuin J, Biasiolo A, Pontisso P, Pierimarchi P, Puoti C, Rasi G. Circulating survivin-IgM is a novel candidate biomarker of cirrhosis and increases with child score in patients affected by liver disease. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 37. | Matteucci C, Sorrentino R, Ettorre G, Bellis L, Antenucci A, Beneduce L, Santoro R, Vennarecci G, Zuin J, Pierimarchi P, Puoti C, Rasi G. Survivin-IgM immuno complex: a novel candidate biomarker of cirrhosis to monitor patients progression towards hepatocellular carcinoma. Monothematic Conference of the Italian Association of the Study of the Liver (AISF). Messina, Italy. 2009. |
| 36. | Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Gatta A, Pontisso P. SERPINB3 and TGF-beta1 correlation in chronic liver disease of viral etiology. International Symposium on Viral Hepatitis and Liver Disease. Washington DC, USA. 2009. |
| 35. | Villano G, Quarta S, Ruvoletto M, Turato C, Biasiolo A, Calabrese F, Dall'Olmo L, Dedja A, Fassina G, Gatta A. Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model. Annual Congress International Liver Cancer Association, (ILCA). Milan, Italy. 2009. |
| 34. | Zani D, Costa S, Gatti L, Pesenti N, Pettenò A, Zambolin T, Simeone C, Cunico S, Leon A, Zuin J, Pengo P, Fassina G, Beneduce L. The association of PSA-IgM and total PSA improves the diagnosis of prostate cancer. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 33. | Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Franzosi L, Pontisso P, Fassina G, Beneduce L. SCCA-IgM usefulness to monitor patients with cirrhosis is not affected by interfering IgM's. Monothematic Conference of the Italian Association of the Study of the Liver (AISF). Messina, Italy. 2009. |
| 32. | Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Toth R, Cerin D, Frecer V, Meo S, Gion M, Fassina G, Beneduce L. Evaluation of analytical specificity of SCCA-IgM assay for monitoring patients with cirrhosis. International Congress, Biochip Development for Cancer Diagnosis. Venice, Italy. 2009. |
| 31. | Beneduce L, Pesce G, Gallotta A, Zampieri F, Biasiolo A, Tono N, Pontisso P, Fassina G. Hepatocellular carcinoma induces specific IgM biomarkers immune complexes. Annual Meeting Italian Association for the Study of the Liver (AISF). Rome, Italy. 2008. |
| 30. | Biasiolo A, Tono N, Turato C, Boscato N, Ruvoletto M, Beneduce L, Fassina G, Gatta A, Pontisso P. Determinazione dell'immunocomplesso VEGF-IgM nellepatocarcinoma. Atti XVIII Conv. Int. Attualità e Prospettive in Epatologia. Padua, Italy. 2008. |
| 29. | Biasiolo A, Tono N, Vidalino L, Turato C, Beneduce L, Leon A, Gatta A, Fassina G, Pontisso P. Vascular endothelial growth factor (VEGF)-IgM complex for the diagnosis of hepatocellular carcinoma. United European Gastroenterology. Vienna, Austria. 2008. |
| 28. | Bucca E, Beneduce L, Leon A, Fabricio A, Michilin S, Steffan A, Durante C, Bellucco C, Rizzo A, Berlanda G, Perasole A, Zampieri F, Fassina G, Gion M. Determination of CA15.3-IgM complexes in sera of breast cancer patients: a new insight to diagnosis. International Conference Cechtuma-EGTM. Plzen, Czech Republic. 2008. |
| 27. | Fassina G, Gallotta A, Beneduce L, Panciatichi C, Rossetto O, Cognolato L. Cancer polymarkers biochips. Nanotec 2008. Venice, Italy. 2008. |
| 26. | Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Fassina G, Gatta A, Pontisso P. Pro-oncogenic effect of Squamous Cell Carcinoma Antigen via wnt/beta-catenin signaling. Annual Congress International Liver Cancer Association, (ILCA). Chicago, USA. 2008. |
| 25. | Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Fassina G, Gatta A, Pontisso P. Serpinb3 promuove l'invasività cellulare. Atti XVIII Con.v Int. Attualità e Prospettive in Epatologia. Padua, Italy. 2008. |
| 24. | Turato C, Biasiolo A, Quarta S, Ruvoletto M, Vidalino L, Villano G, Beneduce L, Zuin J, Fassina G, Gatta A, Pontisso P. Caratterizzazione biologica e funzione della nuova isoforma SCCA-PD. Atti XVIII Con.v Int. Attualità e Prospettive in Epatologia. Padua, Italy. 2008. |
| 23. | Turato C, Navoni F, Biasiolo A, Quarta S, Beneduce L, Zuin J, Fassina G, Gatta A, Pontisso P. Characterization of SCCA-1 (SERPINB3) isoforms in Hepatocellular Carcinoma. Annual Congress International Liver Cancer Association, (ILCA). Chicago, USA. 2008. |
| 22. | Bandiera E, Bignotti E, Ravaggi A, Beneduce L, Tognon G, Franzini R, Romani C, Tassi R, Martinelli F, Gallotta A, Zampieri F, Fassina G, Odicino F, Pecorelli S. Detection of CA125-IgM complexes in sera of early stage epithelial ovarian cancer patients. Annual Meeting Of The Italian Cancer Society (SIC). Aviano-Pordenone, Italy. 2007. |
| 21. | Prayer-Galetti T, Beneduce L, Dal Moro F, Betto G, Fassina G, Pagano F. Influenza dell'età dei pazienti, dei valori di PSA sierico e del grado di differenziazione tumorale sui livelli circolanti degli immunocomplessi PSA-IgM. Congresso Nazionale (SIU). Bari, Italy. 2007. |
| 20. | Turato C, Ruvoletto M, Biasiolo A, Quarta S, Tono N, Bernardinello E, Beneduce L, Fassina G, Cavalletto L, Chemello L, Merkel C, Gatta A, Pontisso P. Polimorfismo di SCCA (squamous cell carcinoma antigen) e progressione della malattia epatica nell'infezione e progressione della malattia epatica nell'infezione HCV. Atti XVII Conv. Int. Attualità e Prospettive in Epatologia. Padua, Italy. 2007. |
| 19. | Vidalino L, Quarta S, Baesso I, Bernardinello E, Ruvoletto M, Frezzato F, Trentin L, Fassina G, Cavalletto L, Chemello L, Gatta A, Pontisso P. Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C. Annual Meeting of the European Association for the Study of the Liver (EASL). Barcelona, Spain. 2007. |
| 18. | Villano G, Quarta S, Ruvoletto M, Calabrese F, Vidalino L, Biasiolo A, Dall'Olmo L, Cozzi E, Fassina G, Gatta A, Pontisso P. Squamous cell carcinoma antigen (SCCA) enhances liver regeneration after partial hepatectomy. Annual Congress International Liver Cancer Association, (ILCA). Barcelona, Spain. 2007. |
| 17. | Beneduce L, Gallotta A, Marino M, Fassina G. Improvement of sensitivity for liver cancer detection by simultaneous evaluation of SCCA-IgM, AFP-IgM complexes and free AFP. Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria. 2006. |
| 16. | Beneduce L, Pesce G, Gallotta A, Fassina G. Des-gamma-carboxyprothrombin-IgM immune complex as novel biomarker for hepatocellular carcinoma. Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria. 2006. |
| 15. | Beneduce L, Prayer-Galetti T, Marcello Grimani Giustinian A, Gallotta A, Fracalanza S, Betto G, Artibani W, Pagano F, Fassina G. The occurrence of prostate specific antigen-IgM immune complexes as novel serum biomarker for prostate cancer. Annual Congress of European Association of Urology. Paris, France. 2006. |
| 14. | Prayer-Galetti T, Beneduce L, Dal Moro F, Betto G, Fassina G, Pagano F. Determinazione del PSA mRNA nel sangue: uno strumento per una migliore caratterizzazione del carcinoma prostatico localizzato. Congresso Nazionale (SIU). Bologna, Italy. 2006. |
| 13. | Quarta S, Vidalino L, Ruvoletto M, Barbera MD, Calabrese F, Valente M, Beneduce L, Gatta A, Fassina G, Pontisso P. SCCA over-expression induces cell proliferation and down-regulation of the adhesion system. International Symposium on Viral Hepatitis and Liver Disease. Paris, France. 2006. |
| 12. | Beneduce L, Castaldi F, Marino M, Pontisso P, Fassina G. Comparison of free and IgM-complexed squamous cell carcinoma antigen in hepatocellular carcinoma. Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 2005. |
| 11. | Quarta S, Caberlotto C, Beneduce L, Castaldi F, Marino M, Fassina G, Tono N, Cavalletto L, Chemello L, Gatta A, Pontisso P. Increase of SCCA-IgM complexes over time are associated with HCC development in cirrhotic patients. 40th Annual Meeting EASL. Paris, France. 2005. |
| 10. | Quarta S, Vidalino L, Ruvoletto M, Della Barbera M, Calabrese F, Valente M, Marino M, Beneduce L, Gatta A, Fassina G, Pontisso P. HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation. Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 2005. |
| 9. | Vidalino L, Quarta S, Baesso I, Cavasin L, Bernardinello E, Trentin L, Fassina G, Cavalletto L, Chemello L, Gatta A, Pontisso P. Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV. Attualità e Prospettive in Epatrologia. Padua, Italy. 2005. |
| 8. | Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Pontisso P, Fassina G. Serological detection of squamous cell carcinoma antigen-IgM complexes in hepatocellular carcinoma. Annual Meeting of the European Association for the Study of the Liver (EASL). Berlin, Germany. 2004. |
| 7. | Nieddu E, Melchiori A, Pescarolo MP, Bagnasco L, Biasotti B, Licheri B, Malacarne D, Tortolina L, Castagnino N, Pasa S, Cimoli G, Avignolo C, Ponassi R, Balbi C, Patrone E, D'Arrigo C, Barboro P, Vasile F, Orecchia P, Carnemolla B, Damonte G, Millo E, Palomba D, Fassina G, Mazzei M, Parodi S. Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-myc. Annual Meeting Of The Italian Cancer Society (SIC). Pisa, Italy. 2004. |
| 6. | Quarta S, Ruvoletto M, Vidalino L, Marino M, Beneduce L, Gatta A, Fassina G, Pontisso P. Biological features of the serine proteinase inhibitor SCCA1 in HCC. Annual Meeting of the European Association for the Study of the Liver (EASL). Berlin, Germany. 2004. |
| 5. | Quarta S, Ruvoletto M, Vidalino L, Tono N, Marino M, Beneduce L, Gatta A, Fassina G, Pontisso P. Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 In HepG2 cells. Annual Meeting Italian Association for the Study of the Liver (AISF). Rome, Italy. 2004. |
| 4. | Fassina G, Marino M, Beneduce L, Frecer V, Burello E, Mestroni L, Miertus S. Combinatorial Proteomic and biomarker discovery. BIOWEST. Aurora, USA. 2003. |
| 3. | Quarta S, Vidalino L, Borgo R, Beneduce L, Marino M, Fassina G, Gatta A, Pontisso P. SCCA1 activates cell proliferation in HepG2 cells: possible role in HCC development. International Meeting on the Molecular Biology of Hepatitis B Viruses. Bergamo, Italy. 2003. |
| 2. | Fassina G, Calabrese F, Ruvoletto M, Marino M, Gatta A, Pontisso P. Immunohistochemical detection of squamous cell carcinoma antigen variants in human liver cancer. International Symposium on the Biology, Structure and Function of Serpins. Chicago IL, USA. 2002. |
| 1. | Ruvoletto M, Marino M, Tono N, Gatta A, Fassina G, Pontisso P. Surface expression of squamous cell carcinoma antigen (SCCA) variants can be upregulated by the pre s1 (21-47) sequence of HBV. Annual Meeting of the European Association for the Study of the Liver (EASL). Madrid, Spain. 2002. |